This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
 Vol. 14 No. 5, November 2005
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dubik, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dubik, M.
Related Collections
Right arrow Clinical Pharmacology and Therapeutics
Right arrow Bioethics

AAP Grand Rounds 14:51-52 (2005)
© 2005 American Academy of Pediatrics

CLINICAL PHARMACOLOGY AND THERAPEUTICS

The Price of Free Samples

Source: Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? Am J Med. 2005;118:881–884.[Medline]

The first 20% of the full text of this article appears below.

To determine whether access to drug samples influences resident prescribing practices, researchers in Minnesota observed 390 decisions to initiate drug therapy by 29 internal medicine residents. The study was conducted over 6 months in an inner-city primary care clinic in Minneapolis. Pharmaceutical company representatives, not allowed contact with the residents, stocked a sample cabinet in the clinic. By random selection, 14 of the residents agreed not to use available free drug samples. Five drug class pairs were chosen for study prospectively. Highly advertised drugs were matched with . . . [Full Text of this Article]

Mike Dubik, MD, FAAP
Pediatrics, Naval Medical Center, San Diego, CA